African Centre for Biodiversity raises concerns over Covid vaccine trials proposed in South Africa. Regarding:
- Non-disclosure of vital safety data and information, which have been redacted as ‘confidential business information’
- Lack of literature references throughout to substantiate health and ecosystem safety claims, making it difficult to evaluate some of the claims being made as to safety
- Lack of evidence of efficacy of the trials
- Lack of information on the test procedures being used
- Concerns regarding the safety claims made